nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—Aclidinium—BCHE—peripheral nervous system neoplasm	0.0264	0.626	CrCbGaD
Mepenzolate—Ageusia—Cisplatin—peripheral nervous system neoplasm	0.02	0.0209	CcSEcCtD
Mepenzolate—Abdominal distension—Tretinoin—peripheral nervous system neoplasm	0.0159	0.0166	CcSEcCtD
Mepenzolate—Abdominal distension—Isotretinoin—peripheral nervous system neoplasm	0.0159	0.0166	CcSEcCtD
Mepenzolate—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.0141	0.0147	CcSEcCtD
Mepenzolate—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.0141	0.0147	CcSEcCtD
Mepenzolate—Urinary retention—Vincristine—peripheral nervous system neoplasm	0.0127	0.0132	CcSEcCtD
Mepenzolate—Abdominal distension—Alitretinoin—peripheral nervous system neoplasm	0.012	0.0126	CcSEcCtD
Mepenzolate—Tension—Tretinoin—peripheral nervous system neoplasm	0.0108	0.0113	CcSEcCtD
Mepenzolate—Tension—Isotretinoin—peripheral nervous system neoplasm	0.0108	0.0113	CcSEcCtD
Mepenzolate—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.0107	0.0111	CcSEcCtD
Mepenzolate—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.0107	0.0111	CcSEcCtD
Mepenzolate—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.0107	0.0111	CcSEcCtD
Mepenzolate—Erectile dysfunction—Vincristine—peripheral nervous system neoplasm	0.0106	0.0111	CcSEcCtD
Mepenzolate—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.0104	0.0108	CcSEcCtD
Mepenzolate—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.0104	0.0108	CcSEcCtD
Mepenzolate—Ageusia—Epirubicin—peripheral nervous system neoplasm	0.0103	0.0107	CcSEcCtD
Mepenzolate—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.00972	0.0101	CcSEcCtD
Mepenzolate—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.00972	0.0101	CcSEcCtD
Mepenzolate—Ageusia—Doxorubicin—peripheral nervous system neoplasm	0.00953	0.00994	CcSEcCtD
Mepenzolate—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.00915	0.00956	CcSEcCtD
Mepenzolate—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.00915	0.00956	CcSEcCtD
Mepenzolate—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00905	0.00945	CcSEcCtD
Mepenzolate—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00905	0.00945	CcSEcCtD
Mepenzolate—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00905	0.00944	CcSEcCtD
Mepenzolate—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00897	0.00937	CcSEcCtD
Mepenzolate—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00897	0.00937	CcSEcCtD
Mepenzolate—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00886	0.00925	CcSEcCtD
Mepenzolate—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00876	0.00914	CcSEcCtD
Mepenzolate—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00876	0.00914	CcSEcCtD
Mepenzolate—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00864	0.00902	CcSEcCtD
Mepenzolate—Tension—Alitretinoin—peripheral nervous system neoplasm	0.00818	0.00854	CcSEcCtD
Mepenzolate—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.00812	0.00847	CcSEcCtD
Mepenzolate—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.00812	0.00847	CcSEcCtD
Mepenzolate—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00809	0.00845	CcSEcCtD
Mepenzolate—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00798	0.00833	CcSEcCtD
Mepenzolate—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00798	0.00833	CcSEcCtD
Mepenzolate—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00785	0.0082	CcSEcCtD
Mepenzolate—Constipation—Topotecan—peripheral nervous system neoplasm	0.00774	0.00808	CcSEcCtD
Mepenzolate—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00767	0.00801	CcSEcCtD
Mepenzolate—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00767	0.00801	CcSEcCtD
Mepenzolate—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00745	0.00778	CcSEcCtD
Mepenzolate—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00739	0.00772	CcSEcCtD
Mepenzolate—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00739	0.00772	CcSEcCtD
Mepenzolate—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00736	0.00769	CcSEcCtD
Mepenzolate—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00719	0.0075	CcSEcCtD
Mepenzolate—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00713	0.00744	CcSEcCtD
Mepenzolate—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00713	0.00744	CcSEcCtD
Mepenzolate—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00704	0.00735	CcSEcCtD
Mepenzolate—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00694	0.00724	CcSEcCtD
Mepenzolate—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00686	0.00716	CcSEcCtD
Mepenzolate—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.0068	0.0071	CcSEcCtD
Mepenzolate—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00669	0.00699	CcSEcCtD
Mepenzolate—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00666	0.00696	CcSEcCtD
Mepenzolate—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00664	0.00693	CcSEcCtD
Mepenzolate—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00661	0.0069	CcSEcCtD
Mepenzolate—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00661	0.0069	CcSEcCtD
Mepenzolate—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00655	0.00684	CcSEcCtD
Mepenzolate—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00653	0.00681	CcSEcCtD
Mepenzolate—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00649	0.00678	CcSEcCtD
Mepenzolate—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00644	0.00672	CcSEcCtD
Mepenzolate—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00644	0.00672	CcSEcCtD
Mepenzolate—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00635	0.00663	CcSEcCtD
Mepenzolate—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00615	0.00642	CcSEcCtD
Mepenzolate—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00605	0.00631	CcSEcCtD
Mepenzolate—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00604	0.00631	CcSEcCtD
Mepenzolate—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00598	0.00624	CcSEcCtD
Mepenzolate—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00593	0.00619	CcSEcCtD
Mepenzolate—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00593	0.00619	CcSEcCtD
Mepenzolate—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00593	0.00619	CcSEcCtD
Mepenzolate—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00582	0.00607	CcSEcCtD
Mepenzolate—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00579	0.00605	CcSEcCtD
Mepenzolate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00575	0.006	CcSEcCtD
Mepenzolate—Fexofenadine—ABCB1—peripheral nervous system neoplasm	0.00573	0.136	CrCbGaD
Mepenzolate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00571	0.00596	CcSEcCtD
Mepenzolate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00571	0.00596	CcSEcCtD
Mepenzolate—Headache—Topotecan—peripheral nervous system neoplasm	0.00567	0.00592	CcSEcCtD
Mepenzolate—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00565	0.0059	CcSEcCtD
Mepenzolate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00563	0.00588	CcSEcCtD
Mepenzolate—Headache—Tretinoin—peripheral nervous system neoplasm	0.00562	0.00587	CcSEcCtD
Mepenzolate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00562	0.00587	CcSEcCtD
Mepenzolate—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.0056	0.00585	CcSEcCtD
Mepenzolate—Constipation—Vincristine—peripheral nervous system neoplasm	0.0056	0.00585	CcSEcCtD
Mepenzolate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.0054	0.00564	CcSEcCtD
Mepenzolate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.0054	0.00564	CcSEcCtD
Mepenzolate—Nausea—Topotecan—peripheral nervous system neoplasm	0.00537	0.00561	CcSEcCtD
Mepenzolate—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00535	0.00559	CcSEcCtD
Mepenzolate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00533	0.00556	CcSEcCtD
Mepenzolate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00533	0.00556	CcSEcCtD
Mepenzolate—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00531	0.00554	CcSEcCtD
Mepenzolate—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.00527	0.0055	CcSEcCtD
Mepenzolate—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00526	0.00549	CcSEcCtD
Mepenzolate—Nausea—Melphalan—peripheral nervous system neoplasm	0.00526	0.00549	CcSEcCtD
Mepenzolate—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00518	0.00541	CcSEcCtD
Mepenzolate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00501	0.00523	CcSEcCtD
Mepenzolate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00488	0.00509	CcSEcCtD
Mepenzolate—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.00487	0.00509	CcSEcCtD
Mepenzolate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00483	0.00504	CcSEcCtD
Mepenzolate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00477	0.00498	CcSEcCtD
Mepenzolate—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00472	0.00493	CcSEcCtD
Mepenzolate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.0047	0.00491	CcSEcCtD
Mepenzolate—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00467	0.00487	CcSEcCtD
Mepenzolate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00466	0.00487	CcSEcCtD
Mepenzolate—Constipation—Etoposide—peripheral nervous system neoplasm	0.00454	0.00474	CcSEcCtD
Mepenzolate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.0045	0.00469	CcSEcCtD
Mepenzolate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00437	0.00457	CcSEcCtD
Mepenzolate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00436	0.00455	CcSEcCtD
Mepenzolate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00433	0.00452	CcSEcCtD
Mepenzolate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00432	0.00451	CcSEcCtD
Mepenzolate—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00432	0.00451	CcSEcCtD
Mepenzolate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00427	0.00446	CcSEcCtD
Mepenzolate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00426	0.00445	CcSEcCtD
Mepenzolate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00422	0.0044	CcSEcCtD
Mepenzolate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00417	0.00435	CcSEcCtD
Mepenzolate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00416	0.00434	CcSEcCtD
Mepenzolate—Headache—Vincristine—peripheral nervous system neoplasm	0.00411	0.00429	CcSEcCtD
Mepenzolate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00404	0.00422	CcSEcCtD
Mepenzolate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00391	0.00408	CcSEcCtD
Mepenzolate—Nausea—Vincristine—peripheral nervous system neoplasm	0.00389	0.00406	CcSEcCtD
Mepenzolate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00381	0.00398	CcSEcCtD
Mepenzolate—Fentanyl—ABCB1—peripheral nervous system neoplasm	0.00379	0.0898	CrCbGaD
Mepenzolate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00368	0.00385	CcSEcCtD
Mepenzolate—Loperamide—ABCB1—peripheral nervous system neoplasm	0.00365	0.0865	CrCbGaD
Mepenzolate—Tension—Epirubicin—peripheral nervous system neoplasm	0.00358	0.00374	CcSEcCtD
Mepenzolate—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00354	0.0037	CcSEcCtD
Mepenzolate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00351	0.00366	CcSEcCtD
Mepenzolate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00344	0.00359	CcSEcCtD
Mepenzolate—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00344	0.00359	CcSEcCtD
Mepenzolate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00338	0.00352	CcSEcCtD
Mepenzolate—Headache—Etoposide—peripheral nervous system neoplasm	0.00333	0.00347	CcSEcCtD
Mepenzolate—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00331	0.00346	CcSEcCtD
Mepenzolate—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00328	0.00342	CcSEcCtD
Mepenzolate—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00322	0.00336	CcSEcCtD
Mepenzolate—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00318	0.00332	CcSEcCtD
Mepenzolate—Nausea—Etoposide—peripheral nervous system neoplasm	0.00315	0.00329	CcSEcCtD
Mepenzolate—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00304	0.00317	CcSEcCtD
Mepenzolate—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.003	0.00313	CcSEcCtD
Mepenzolate—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00298	0.00311	CcSEcCtD
Mepenzolate—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00298	0.00311	CcSEcCtD
Mepenzolate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.0029	0.00303	CcSEcCtD
Mepenzolate—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00281	0.00293	CcSEcCtD
Mepenzolate—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00278	0.0029	CcSEcCtD
Mepenzolate—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00275	0.00287	CcSEcCtD
Mepenzolate—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00269	0.00281	CcSEcCtD
Mepenzolate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00269	0.00281	CcSEcCtD
Mepenzolate—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00265	0.00276	CcSEcCtD
Mepenzolate—Methadone—ABCB1—peripheral nervous system neoplasm	0.0026	0.0616	CrCbGaD
Mepenzolate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00254	0.00266	CcSEcCtD
Mepenzolate—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00249	0.0026	CcSEcCtD
Mepenzolate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00245	0.00256	CcSEcCtD
Mepenzolate—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00245	0.00256	CcSEcCtD
Mepenzolate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00236	0.00247	CcSEcCtD
Mepenzolate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00235	0.00246	CcSEcCtD
Mepenzolate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00227	0.00237	CcSEcCtD
Mepenzolate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00219	0.00229	CcSEcCtD
Mepenzolate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00219	0.00228	CcSEcCtD
Mepenzolate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00213	0.00223	CcSEcCtD
Mepenzolate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00203	0.00212	CcSEcCtD
Mepenzolate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00198	0.00206	CcSEcCtD
Mepenzolate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00197	0.00205	CcSEcCtD
Mepenzolate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00189	0.00198	CcSEcCtD
Mepenzolate—Headache—Epirubicin—peripheral nervous system neoplasm	0.00186	0.00195	CcSEcCtD
Mepenzolate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00182	0.0019	CcSEcCtD
Mepenzolate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00177	0.00185	CcSEcCtD
Mepenzolate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00175	0.00183	CcSEcCtD
Mepenzolate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00172	0.0018	CcSEcCtD
Mepenzolate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00164	0.00171	CcSEcCtD
